CRBU Q2 2022 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$181M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+184.0% YoY

Gross Profit

-$18M-438.6% margin

Operating Income

-$28M-678.2% margin

Net Income

-$27M-636.9% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+57.4%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$24M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$421M

Total Liabilities

$73M

Stockholders' Equity

$348M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$1M	+184.0%
Gross Profit	-$18M	$1M	-1345.7%
Operating Income	-$28M	-$16M	-78.1%
Net Income	-$27M	-$14M	-86.5%

Geographic Segments

UNITED STATES

$4M100%

Non-US

$9,0000%